Institute of Molecular Infection Biology, University of Würzburg, Würzburg, Germany.
Institute of Microbiology and Epizootics, Centre for Infection Medicine, School of Veterinary Medicine, Freie Universität Berlin, Berlin, Germany.
Front Immunol. 2023 Mar 10;14:1127709. doi: 10.3389/fimmu.2023.1127709. eCollection 2023.
Humanized hemato-lymphoid system mice, or humanized mice, emerged in recent years as a promising model to study the course of infection of human-adapted or human-specific pathogens. Though infects and colonizes a variety of species, it has nonetheless become one of the most successful human pathogens of our time with a wide armory of human-adapted virulence factors. Humanized mice showed increased vulnerability to compared to wild type mice in a variety of clinically relevant disease models. Most of these studies employed humanized NSG (NOD- IL2Rg) mice which are widely used in the scientific community, but show poor human myeloid cell reconstitution. Since this immune cell compartment plays a decisive role in the defense of the human immune system against , we asked whether next-generation humanized mice, like NSG-SGM3 (NOD-scid IL2Rg-3/GM/SF) with improved myeloid reconstitution, would prove to be more resistant to infection. To our surprise, we found the contrary when we infected humanized NSG-SGM3 (huSGM3) mice with : although they had stronger human immune cell engraftment than humanized NSG mice, particularly in the myeloid compartment, they displayed even more pronounced vulnerability to infection. HuSGM3 mice had overall higher numbers of human T cells, B cells, neutrophils and monocytes in the blood and the spleen. This was accompanied by elevated levels of pro-inflammatory human cytokines in the blood of huSGM3 mice. We further identified that the impaired survival of huSGM3 mice was not linked to higher bacterial burden nor to differences in the murine immune cell repertoire. Conversely, we could demonstrate a correlation of the rate of humanization and the severity of infection. Collectively, this study suggests a detrimental effect of the human immune system in humanized mice upon encounter with which might help to guide future therapy approaches and analysis of virulence mechanisms.
人源化血-淋巴系统小鼠,或人源化小鼠,近年来作为研究人类适应或人类特异性病原体感染过程的一种有前途的模型而出现。虽然 可以感染和定植多种物种,但它仍然成为我们这个时代最成功的人类病原体之一,具有广泛的人类适应毒力因子库。与人源化 NSG(NOD-IL2Rg)小鼠相比,人源化小鼠在多种临床相关疾病模型中对 表现出更高的易感性,NSG(NOD-IL2Rg)小鼠在科学界被广泛使用,但骨髓细胞的重建能力较差。由于这个免疫细胞群在人类免疫系统抵御 方面起着决定性的作用,我们想知道是否像 NSG-SGM3(NOD-scid IL2Rg-3/GM/SF)这样的下一代人源化小鼠,具有改善的骨髓细胞重建能力,是否会对感染更有抵抗力。令我们惊讶的是,当我们用 感染人源化 NSG-SGM3(huSGM3)小鼠时,我们发现了相反的结果:尽管它们的人免疫细胞植入比人源化 NSG 小鼠更强,特别是在骨髓细胞群中,但它们对 感染的易感性甚至更为明显。huSGM3 小鼠的血液和脾脏中的人 T 细胞、B 细胞、中性粒细胞和单核细胞总数更高。这伴随着 huSGM3 小鼠血液中促炎细胞因子水平的升高。我们进一步发现,huSGM3 小鼠的存活率降低与更高的细菌负荷或与鼠免疫细胞库的差异无关。相反,我们可以证明人源化的速度与人感染的严重程度之间存在相关性。总的来说,这项研究表明人类免疫系统在遇到 时对人源化小鼠产生有害影响,这可能有助于指导未来的治疗方法和分析毒力机制。